±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 2541  |  »Ø¸´: 23
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

286293287

½ð³æ (СÓÐÃûÆø)

[½»Á÷] Ò©Æ·×¢²áÓÃÓ¢Óï

Ò©Æ·×¢²áÓÃÓ¢Óï


ÏÖÔÚ×ö×¢²á×ÊÁϾ­³£»áÉæ¼°Ó¢Óï±í´ï£¬ÎªÁËʹÎÒÃÇдע²á×ÊÁÏʱµÄÓ¢Óï¸ü´¿Õý£¬Ï£Íû¸÷λ´ïÈËÄÜ»ý¼«ÓÂÔ¾Ìṩ¾­³£Éæ¼°µÄÓ¢Óï±í´ï£¬Ê¹ÎÒÃǵÄ×¢²áˮƽ¸üÉÏÒ»²ãÂ¥¡£
ÎÒÏÈÅ×שÒýÓñ
CEP£ºÅ·ÖÞÒ©µäÊÊÓ¦ÐÔÖ¤Êécertificate of suitability to monograph of European Pharmacopoeia¡£ÊÇÅ·ÖÞÒ©µäËùÊÕÔØµÄÔ­ÁÏÒ©µÄÒ»ÖÖÈÏÖ¤³ÌÐò£¬ÓÃÒÔÈ·¶¨Ô­ÁÏÒ©µÄÖÊÁ¿¿ÉÒÔÓÃÅ·ÖÞÒ©µäµÄ·½·¨¼ÓÒÔ¿ØÖÆ¡£ÕâÒ»³ÌÐòÊÊÓÃÓÚÉú²úµÄºÍÌáÈ¡µÄÓлú»òÎÞ»úÎïÖÊÒÔ¼°·¢½ÍÉú²úµÄ·ÇÖ±½Ó»ùÒò²úÆ·¡£
DMF£ºDrug master FileÃÀ¹úÒ©ÎïÖ÷Îļþµµ°¸¡£ÊÇÖ¸Ìá½»¸øFDAµÄÓÃÓÚÌṩ¹ØÓÚÈËÓÃÒ©Æ·µÄÉú²úÉ豸¡¢¹¤ÒÕ»òÉú²ú¡¢¹¤ÒÕ´¦Àí¡¢°ü×°ºÍ´¢´æÖÐʹÓõÄÎïÁϵÄÏêϸµÄºÍ±£ÃܵÄÐÅÏ¢¡£·ÖΪÎåÖÖÀàÐÍ£º
I£º Éú²úµØµã¡¢É豸¡¢²Ù×÷³ÌÐòºÍÈËÔ±
II£º Ô­ÁÏÒ©¡¢Ô­ÁÏÒ©ÖмäÌå¡¢Éú²úÔ­ÁÏÒ©ºÍÖмäÌåʹÓõÄÎïÁϺÍÒ©Æ·
III£º°ü×°²ÄÁÏ
IV£º¸³ÐμÁ¡¢É«ËØ¡¢µ÷ζ¼Á¡¢ÏãÁÏ»òÉú²úÕâЩÎïÖÊËùÓõÄÎïÁÏ
V£º FDA½ÓÊܵIJο¼ÐÅÏ¢

EDMF£ºEuropean Drug Master FileÅ·ÖÞÒ©ÎïÖ÷Îļþµµ°¸¡£ÊÇָŷÖÞÖÆ¼ÁÉêÇëÖÐÓйØÔ­ÁÏÒ©ÐÅÏ¢µÄÎļþ£¬ÓÖ³ÆÔ­ÁÏÒ©Ö÷Îļþµµ°¸£¨ASMF£©¡£EDMF Ö»ÓÐÔÚÖÆ¼ÁÉêÇëµÄÖ§³ÖϲÅÄÜÌá½»¡£EDMF·ÖΪÁ½²¿·Ö£º
1£® ÉêÇëÈ˲¿·Ö£¨AP£©£º¹©ÖƼÁÉêÇëÈËʹÓõķDZ£ÃÜÐÅÏ¢£»
2. ÏÞÖÆ²¿·Ö£¨RP£©£ºEDMF³ÖÓÐÈËÈÏΪÊDZ£ÃܵÄÐÅÏ¢¡£
EDMFµÄʹÓ÷¶Î§£º
1. ÐÂÔ­ÁÏÒ©
2. ÒÑÖªµÄµ«Å·ÖÞÒ©µä»òÆä³ÉÔ±¹úÒ©µäûÓÐÊÕÔØµÄÔ­ÁÏÒ©
3. Å·ÖÞÒ©µä»ò³ÉÔ±¹úÒ©µäÒÑÊÕÔØµÄÔ­ÁÏÒ©
ANDA£ºAbbreviated New Drug Application ÃÀ¹ú¼òÂÔÐÂÒ©ÉêÇë¡£ÊÇFDA¹æ¶¨µÄ·ÂÖÆÒ©ÉêÇë³ÌÐò¡£
Generic£º·ÂÖÆµÄ£¬·ÇÌØÊâµÄ
API£ºActive Pharmaceutical Ingredient Ô­ÁÏÒ©
Dossier£ºÎĵµ£¬µµ°¸¡£
TSE£ºTransmitting animal Spongiform Encephalopathy agent ´«²¥ÐÔ¶¯ÎﺣÃà×´ÄÔ²¡Ìå
Q7A£ºICH£¨¹ú¼ÊЭµ÷»áÒ飩 Ô­ÁÏÒ©GMP Ö¸ÄÏ¡£²ûÊöÁËÔ­ÁÏÒ©Éú²úÉÌÓ¦×ñÑ­µÄGMPÖ¸µ¼Ô­Ôò¡£
Start Material£º¼ò³ÆSM£¬ÆðʼÎïÁÏ¡£ÆðʼÎïÁÏͨ³£±êÖ¾×ÅÉú²ú¹ý³ÌµÄ¿ªÊ¼¡£ºÏ³É¹¤ÒÕÔ­ÁÏÒ©µÄÆðʼÎïÁÏÊÇÖ¸¹¹³ÉÔ­ÁÏÒ©Ö÷Òª½á¹¹Æ¬¶ÏµÄÒ»ÖÖÔ­²ÄÁÏ¡¢ÖмäÌå»òÕßÔ­ÁÏÒ©£»Ëü¿ÉÒÔÊÇÒ»ÖÖÉÌÆ·£¬Ò²¿ÉÒÔÊÇÄÚ²¿Éú²úµÄÎïÖÊ£»ÆðʼÎïÁÏÒ»°ã¾ßÓÐÃ÷È·µÄÐÔÖʺͽṹ¡£
BPR£ºBritish Pharmacopoeia Reference Ó¢¹úÒ©µä¶ÔÕÕÆ·
EPR£ºEuropean Pharmacopoeia Reference Å·ÖÞÒ©µä¶ÔÕÕÆ·
COA£ºCertificate Of Analysis ·ÖÎö±¨¸æµ¥
Food Additive£ºÊ³Æ·Ìí¼Ó¼Á¡£FDA ¶ÔʳƷÌí¼Ó¼ÁµÄ¶¨ÒåÊÇÖ¸ÈκÎÒ»ÖÖÎïÖÊ£¬ËüµÄÔ¤ÆÚµÄÓÃ;¿ÉÒÔ»ò±»ÆÚÍû¿ÉÒÔÖ±½Ó»ò¼ä½ÓµØÊ¹ÕâÖÖÎïÖʳÉΪijһʳƷÖеijɷֻòÓ°ÏìʳƷµÄÌØÕ÷¡£GRASÎïÖʼ°ÎÞÉøÒÆ»ò¼«ÉÙÉøÒÆµÄʳƷ½Ó´¥ÐÔÎïÖʳýÍâ¡£
Dietary Supplement£º Òûʳ²¹³ä¼Á¡£ÃÀ¹ú£±£¹£¹£´Äê°ä²¼µÄ¡¶Òûʳ²¹³ä¼Á½¡¿µÓë½ÌÓý·¨¡·£¨£Ä£Ó£È£Å£Á£©ÖУ¬È·Á¢ÁËÒûʳ²¹³ä¼ÁµÄ¶¨Òå¡£Òûʳ²¹³ä¼ÁÊÇÖ¸º¬ÓС°Òûʳ³É·Ö¡±µÄ¿Ú·þ²úÆ·¡£Õâ Щ²úÆ·ÖÐËùº¬Óеġ°Òûʳ³É·Ö¡±°üÀ¨£ºÎ¬ÉúËØ¡¢¿óÉúÎï¡¢²Ý±¾»òÆäËûÖ²Îï¡¢°±»ùËᣬÒÔ¼°Ã¸¡¢Æ÷¹Ù×éÖ¯¡¢ÏÙÌåºÍ´úлÎïÖ®ÀàµÄÎïÖÊ¡£Òûʳ²¹³ä¼ÁÒ²¿ÉÒÔÊÇÝÍÈ¡Îï»òŨ ËõÎ¶øÇÒ¿ÉÒÔÖÆ³ÉƬ¼Á¡¢½ºÄÒ¡¢Èí½ºµÈ¶àÖÖÐÎʽ¡£

[ Last edited by shich68 on 2008-5-6 at 09:37 ]
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

harrisonzhang

ľ³æ (³õÈëÎÄ̳)

ÇëÎÊÄãÊÇ´ÓÊÂÔ­ÁÏÒ©¹ú¼Ê×¢²áµÄ£¿£¯£¿
º»Êµ»ù´¡£¬×·Çó׿Խ
2Â¥2007-12-12 02:50:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

286293287

½ð³æ (СÓÐÃûÆø)

ºÜ¶à£¬Ò©Æ·¡¢Æ÷еµÈµÈ£¡ºÇºÇ£¬Ð»Ð»¹Ø×¢
3Â¥2007-12-12 09:54:15
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

qingerzheng

гæ (СÓÐÃûÆø)

great , very benefitable
4Â¥2008-01-03 14:09:45
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

À¶Ìì°×ÔÆ263

Òø³æ (³õÈëÎÄ̳)

ллÁË£¡²»´í£¡
5Â¥2008-03-01 09:46:26
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

°®¿´ÐÇÐǵÄÓã

Òø³æ (СÓÐÃûÆø)

ºÜʵÓÃ,лл·ÖÏí~
6Â¥2008-03-04 11:28:48
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hxwhu

ľ³æ (СÓÐÃûÆø)

²¹ÉÏ£º

FDAÓйØÊõÓï

·¢²¼Ê±¼ä£º2005-04-13

FDA£¨food and drug administration£©£º
£¨ÃÀ¹ú£©Ê³Æ·Ò©Æ·¹ÜÀí¾Ö

IND£¨investigational new drug£©£º
ÁÙ´²Ñо¿ÉêÇ루ָÉ걨½×¶Î,Ïà¶ÔÓÚNDA¶øÑÔ£©£»
Ñо¿ÖеÄÐÂÒ©£¨Ö¸ÐÂÒ©¿ª·¢½×¶Î£¬Ïà¶ÔÓÚÐÂÒ©¶øÑÔ£¬¼´ÁÙ´²Ç°Ñо¿½áÊø£©

NDA£¨new drug application£©£ºÐÂÒ©ÉêÇë

ANDA£¨abbreviated new drug application£©£º¼ò»¯ÐÂÒ©ÉêÇë

epËߣ¨export application£©£º
³ö¿ÚÒ©ÉêÇ루ÉêÇë³ö¿Ú²»±»Åú×¼ÔÚÃÀ¹úÏúÊÛµÄÒ©Æ·£©

treatment IND£ºÑо¿ÖеÄÐÂÒ©ÓÃÓÚÖÎÁÆ

abbreviated£¨new£©drug£º¼ò»¯ÉêÇëµÄÐÂÒ©

DMF£¨drug master file£©£º
Ò©ÎïÖ÷Îļþ£¨³ÖÓÐÕßΪ½÷É÷Æð¼û¶ø×¼±¸µÄ±£ÃÜ×ÊÁÏ£¬¿ÉÒÔ°üÀ¨Ò»¸ö»ò¶à¸öÈËÓÃÒ©ÎïÔÚÖÆ±¸¡¢¼Ó¹¤¡¢°ü×°ºÍÖü´æ¹ý³ÌÖÐËùÉæ¼°µÄÉ豸¡¢Éú²ú¹ý³Ì»òÎïÆ·¡£Ö»ÓÐÔÚdmf³ÖÓÐÕß»òÊÚȨ´ú±íÒÔÊÚȨÊéµÄÐÎʽÊÚȨ¸øfda£¬fdaÔÚÉó²éind¡¢nda¡¢andaʱ²ÅÄܲο¼ÆäÄÚÈÝ£©

holder£ºDMF³ÖÓÐÕß

CFR£¨code of federal regulation£©£º£¨ÃÀ¹ú£©Áª°î·¨¹æ

panel£º×¨¼ÒС×é

batch production£ºÅúÁ¿Éú²ú£»·ÖÅúÉú²ú

batch production records£ºÉú²úÅúºÅ¼Ç¼

post-or pre- market surveillance£ºÏúÊÛǰ»òÏúÊÛºó¼à¶½

informed consent£º
ÖªÇéͬÒ⣨»¼Õß¶ÔÖÎÁÆ»òÊÜÊÔÕß¶ÔÒ½ÁÆÊÔÑéÁ˽âºó±íʾͬÒâ½ÓÊÜÖÎÁÆ»òÊÔÑ飩

prescription drug£º´¦·½Ò©

OTC drug£¨over¡ªthe¡ªcounter drug£©£º·Ç´¦·½Ò©

U£®S£®public health service£ºÃÀ¹úÎÀÉú¸£Àû²¿

NIH£¨national institute of health£©£º£¨ÃÀ¹ú£©È«¹úÎÀÉúÑо¿Ëù

clinical trial£ºÁÙ´²ÊÔÑé

animal trial£º¶¯ÎïÊÔÑé

accelerated approval£º¼ÓËÙÅú×¼

standard drug£º±ê×¼Ò©Îï

investigator£ºÑо¿ÈËÔ±£»µ÷ÑÐÈËÔ±

preparing and submitting£ºÆð²ÝºÍÉ걨

submission£ºÉ걨£»µÝ½»

benifit£¨s£©£ºÊÜÒæ

risk£¨s£©£ºÊܺ¦

drug product£ºÒ©Îï²úÆ·

drug substance£ºÔ­ÁÏÒ©

established name£ºÈ·¶¨µÄÃû³Æ

generic name£º·ÇרÀûÃû³Æ

proprietary name£º×¨ÓÐÃû³Æ£»

INN£¨international nonproprietary name£©£º¹ú¼Ê·ÇרÓÐÃû³Æ

narrative summary¼ÇÐðÌå¸ÅÒª

adverse effect£º¸±×÷ÓÃ

adverse reaction£º²»Á¼·´Ó¦

protocol£º·½°¸

archival copy£º´æµµÓø±±¾

review copy£ºÉó²éÓø±±¾

official compendium£º·¨¶¨Ò©µä£¨Ö÷ÒªÖ¸usp¡¢nf£©

USP£¨the united states pharmacopeia£©£ºÃÀ¹úÒ©µä£¨ÏÖÒѺÍnfºÏ²¢Ò»Æð³ö°æ£©

NF£¨national formulary£©£º£¨ÃÀ¹ú£©¹ú¼ÒÒ©Æ·¼¯

official£½pharmacopeial= compendial£ºÒ©µäµÄ£»·¨¶¨µÄ£»¹Ù·½µÄ

agency£ºÉóÀí²¿ÃÅ£¨Ö¸fda£©

sponsor£ºÖ÷°ìÕߣ¨Ö¸¸ºÔð²¢×ÅÊÖÁÙ´²Ñо¿Õߣ©

identity£ºÕæÎ±£»¼ø±ð£»ÌØÐÔ

strength£º¹æ¸ñ£»¹æ¸ñº¬Á¿£¨Ã¿Ò»¼ÁÁ¿µ¥Î»Ëùº¬ÓÐЧ³É·ÖµÄÁ¿£©

labeled amount£º±êʾÁ¿

regulatory specification£ºÖÊÁ¿¹ÜÀí¹æ¸ñ±ê×¼£¨ndaÌṩ£©

regulatory methodology£º
ÖÊÁ¿¹ÜÀí·½·¨£¨fdaÓÃÓÚ¿¼ºËÔ­ÁÏÒ©»òÒ©Îï²úÆ·ÊÇ·ñ·ûºÏÅú×¼Á˵ÄÖÊÁ¿¹ÜÀí¹æ¸ñ±ê×¼µÄÕûÌײ½Ö裩

regulatory methods validation£º
¹ÜÀíÓ÷ÖÎö·½·¨µÄÑéÖ¤£¨fda¶ÔndaÌṩµÄ·½·¨½øÐÐÑéÖ¤£©

dietary supplement£ºÊ³Óò¹³äÆ·
7Â¥2008-03-04 11:33:00
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

robbiekean

ľ³æ (ÕýʽдÊÖ)

ÖØ¸´Ìû×Ó°É,±ðÈËÔç·¢¹ýÁË!
8Â¥2008-03-11 08:07:28
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

bearbear519

ºÃ£¡Öظ´µÄÌû×Ó¶ÔÎÒÒ²ÓÐÓÃŶ£¡£¡ºÇºÇ
9Â¥2008-03-11 23:23:59
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

bearbear519

ºÃ£¡Öظ´µÄÌû×Ó¶ÔÎÒÒ²ÓÐÓÃŶ£¡£¡ºÇºÇ
10Â¥2008-03-11 23:25:09
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ 286293287 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 289Çóµ÷¼Á +13 ÐÂʱ´ú²ÄÁÏ 2026-03-27 13/650 2026-03-29 01:16 by 544594351
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +6 ´Þwj 2026-03-26 6/300 2026-03-29 01:11 by hanserlol
[¿¼ÑÐ] Çóµ÷¼ÁÒ»Ö¾Ô¸º£´ó£¬0703»¯Ñ§Ñ§Ë¶304·Ö£¬Óдó´´ÏîÄ¿£¬Ëļ¶Òѹý +7 ÐÒÔËÁ¨Á¨ 2026-03-22 11/550 2026-03-28 20:27 by ÌÆãå¶ù
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +3 raojunqi0129 2026-03-28 3/150 2026-03-28 15:27 by ÂäÉ˼
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¹¤Òµ´óѧ£¬324·ÖÇóµ÷¼Á +4 Áã°Ë# 2026-03-28 4/200 2026-03-28 15:01 by 17865157980
[¿¼ÑÐ] 0703±¾¿ÆÖ£ÖÝ´óѧÇóµ÷¼Á +3 nhj_ 2026-03-25 3/150 2026-03-28 13:24 by Iveryant
[¿¼ÑÐ] ²ÄÁÏ277Çóµ÷¼Á +7 min3 2026-03-24 7/350 2026-03-28 11:39 by xuxiang
[¿¼ÑÐ] ҩѧ105500Çóµ÷¼Á +3 Ssun¡£¡£ 2026-03-28 3/150 2026-03-28 11:24 by lxf170613
[¿¼ÑÐ] 340Çóµ÷¼Á +5 jhx777 2026-03-27 5/250 2026-03-28 04:18 by fmesaito
[¿¼ÑÐ] Çóµ÷¼ÁÍÆ¼ö ²ÄÁÏ 304 +15 ºÉ°üµ°hyj 2026-03-26 15/750 2026-03-28 04:13 by fmesaito
[¿¼ÑÐ] 322Çóµ÷¼Á +4 ÎÒÕæµÄºÜÏëѧϰ 2026-03-23 4/200 2026-03-27 13:51 by ÑîÑîÑî×Ï
[¿¼ÑÐ] Ò»Ö¾Ô¸Ö£´ó085600£¬310·ÖÇóµ÷¼Á +5 Àîäì¿É 2026-03-26 5/250 2026-03-27 11:14 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 292Çóµ÷¼Á +4 ÇóÇóÁËÊÕÏÂÎÒ°É£ 2026-03-26 4/200 2026-03-27 10:37 by zhshch
[¿¼ÑÐ] 359Çóµ÷¼Á +4 ÍõÁ˸öéª 2026-03-25 4/200 2026-03-27 08:43 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] ×Ü·Ö293Çóµ÷¼Á +6 ¼ÓÒ»Ò»¾Å 2026-03-25 8/400 2026-03-26 13:30 by yujianx
[¿¼ÑÐ] ´ò¹ýºÜ¶à¾ºÈü£¬085406¿ØÖƹ¤³Ì300·Ö£¬Çóµ÷¼Á +3 askeladz 2026-03-26 3/150 2026-03-26 09:08 by ¸øÄãÄã×¢ÒâÐÝÏ¢
[¿¼ÑÐ] 303Çóµ÷¼Á +6 À¶É½Ô 2026-03-25 6/300 2026-03-25 22:47 by 418490947
[¿¼ÑÐ] 26¿¼ÑÐ-291·Ö-ÏÃÃÅ´óѧ£¨085601£©-ÈáÐÔµç×ÓѧԺ²ÄÁϹ¤³ÌרҵÇóµ÷¼Á +3 min3 2026-03-24 4/200 2026-03-25 18:22 by xcjcqu
[¿¼ÑÐ] 361Çóµ÷¼Á +3 Glack 2026-03-22 3/150 2026-03-23 22:03 by fuyu_
[¿¼ÑÐ] 328Çóµ÷¼Á +4 LHHL66 2026-03-23 4/200 2026-03-23 14:55 by lbsjt
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û